The Association Between SLIT2 in Human Vitreous Humor and Plasma and Neurocognitive Test Scores
Sara I. ShoushtariiD, Easton J. Liaw, Sreevardhan Alluri, Zahra SheikhiD, Sudhir KumariD, Courtney Huynh, Insa Marie SchmidtiD, Steven D. NessiD, Xuejing CheniD, Nicole H. SiegeliD, Sushrut S. WaikariD, Thor D. SteiniD, Weining LuiD, Manju L. SubramanianiD
Abstract
BackgroundSlit Guidance Ligand 2 (SLIT2) binds Roundabout (ROBO) guidance receptors to direct axon pathfinding and neuron migration during nervous system development. SLIT2 expression has previously been linked to dementia risk. ObjectiveTo study the association between SLIT2 expression in human vitreous humor and plasma samples and neurocognitive test scores in a cross-sectional cohort study utilizing a novel, highly-sensitive Meso Scale Discovery (MSD) assay for SLIT2 detection. MethodsSeventy-nine individuals with a mean age of 55.79 {+/-} 12.03 years underwent eye surgery with collection of vitreous humor, blood (plasma) collection, and neurocognitive assessment. Vitreous humor and plasma samples were analyzed by SLIT2 MSD electrochemiluminescence immunoassay. Associations between SLIT2 levels in vitreous humor and plasma were analyzed using GraphPad Prism. ResultsWe found up to a 7-fold higher level of SLIT2 in human vitreous humor compared to plasma. Lower vitreous SLIT2 levels were associated with a lower Montreal Cognitive Assessment (MoCA) score and Immediate Recall Verbatim (IRV) z-score, and higher plasma SLIT2 was associated with a lower MoCA score. In multivariate analysis using single and multiple predictor models, the same significant associations were found when adjusted for age, sex, race, diabetic status, diabetic retinopathy status, glaucoma status, and Apolipoprotein E (APOE) genotype. ConclusionsSLIT2 protein levels are significantly associated with MoCA score and IRV z-score in middle-aged individuals. The relationship remained significant when adjusted for demographics, co-morbidity, and APOE genotype, suggesting SLIT2 may be a sensitive biomarker for detection of mild cognitive impairment and early dementia, and warrants further studies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.67
- Field percentile
- top 29%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased circulating TREM2+ microglia extracellular vesicles in aged APP/PS1 Alzheimer's disease rats
Sarah J. Myers, Manoj Reddy Medapati, … Austyn D. Roseborough·Brain Behavior & Immunity - HealthPeer-reviewed·May 14, 2026
- Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid
Lindsay R. Clark, Sara Elizabeth Berman, … Cynthia M. Carlsson·NeurologyPeer-reviewed·Mar 9, 2018
- UP-REGULATION OF SYNAPTOBREVIN-2 TO DELAY AGE-RELATED COGNITIVE IMPAIRMENT
Jacob Bradford Miller, Ankit Seth, … Ferenc Deák·bioRxiv·May 8, 2026
- Type-2-diabetes alters CSF but not plasma metabolomic and AD risk profiles in vervet monkeys
Kylie Kavanagh, Stephen M. Day, … Shannon L. Macauley·Frontiers in NeurosciencePeer-reviewed·Aug 28, 2019
- Reduced levels of synaptic vesicle protein 2A in the extracellular vesicles and brain of Alzheimer's disease- associations with Aβ, tau and synaptophysin
Jana Nussbaumer, Aatmika Barve, … Ruiqing Ni·bioRxiv·Jan 21, 2025
- Microglial expression of the Wnt signalling modulator DKK2 differs between human Alzheimer's disease brains and mouse neurodegeneration models
Nozie D. Aghaizu, Sarah Jolly, … Paul John Whiting·bioRxiv·May 5, 2022